Cultivated autologous limbal epithelial cell (Massachusetts Eye and Ear Infirmary)

N/A

Report date: 2022/11/20 22:31:38

Base Information

Drug NameCultivated autologous limbal epithelial cell (Massachusetts Eye and Ear Infirmary)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Limbal epithelial cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLimbal Stem Cell DeficiencyCorneal Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMassachusetts Eye And Ear

China Registration ClassN/A

Develop Information

Active CompaniesMassachusetts Eye And Ear

Inactive CompaniesN/A

Active IndicationsLimbal Stem Cell DeficiencyCorneal Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A